Core Insights - Qingdao's private economy development bureau announced the list of leading benchmark enterprises for 2025, with Chenlan Health Industry Group recognized for its innovative achievements in health product research and comprehensive industry layout [1][5] - This award follows previous recognitions for Chenlan Health, including "Qingdao Marine High-Growth Enterprise," "Shandong Province Gazelle Enterprise," and "Innovative Enterprise of Science and Technology in China" [1] Company Overview - Established 20 years ago, Chenlan Health adheres to the mission of "based on biotechnology, benefiting human health," focusing on the "ocean + traditional Chinese medicine" industry development direction [2] - The company has built three major research bases and four industrial bases, creating a comprehensive health industry chain covering brand raw materials, dietary supplements, ecological safe ingredients, e-commerce, new traditional Chinese medicine, and medical devices [2] Strategic Development - Chenlan Health operates multiple brands, including Xinkangrui, Kang'er Biology, Shenzhou Youpin, Yishengkang, and Silver Century, integrating research, production, warehousing, logistics, and sales into a high-tech enterprise [3] - The company actively promotes public health initiatives and has undertaken various social responsibility projects, such as the "National Silver Age Health Project" and donations to build schools and support COVID-19 relief efforts [3] Future Outlook - The recognition as a "2025 Leading Benchmark Enterprise" is seen as validation of Chenlan Health's commitment to technological innovation and high-quality development [5] - Looking ahead, the company aims to continue its mission of providing scientific, professional, and compassionate health care, contributing to the "Healthy China" initiative [5]